{"entity":{"type":"insider","cik":"0001709113","url":"/insider/0001709113","json_url":"/insider/0001709113.json","name":"Cavanaugh Sarah","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2020-06-11","last":"2024-06-03","span_basis":"filed_date"},"name_variants":[{"name":"Cavanaugh Sarah","source":"filing","n_filings":5,"first_seen":"2020-06-11","last_seen":"2024-06-03"}],"transactions":[{"id":3236635,"accession":"0001415889-24-015138","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-015138","line_url":"/filing/0001415889-24-015138#line-3","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709113","owner_name":"Cavanaugh Sarah","owner_display_name":"Cavanaugh Sarah","owner_url":"/insider/0001709113","role":"Officer (SVP OF CORP AFFAIRS & ADMIN)","role_mark":"O","role_mark_label":"Officer (SVP OF CORP AFFAIRS & ADMIN)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP OF CORP AFFAIRS & ADMIN.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20853.0,"shares_display":"20,853","price_per_share":33.7282,"price_display":"33.73","price_state":"stated","total_value":703334.1546,"total_display":"703,334.15","total_whole":"703,334","shares_owned_after":1860.0,"shares_owned_after_display":"1,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":6425776,"accession":"0001415889-22-008896","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-22-008896","line_url":"/filing/0001415889-22-008896#line-4","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709113","owner_name":"Cavanaugh Sarah","owner_display_name":"Cavanaugh Sarah","owner_url":"/insider/0001709113","role":"Officer (SVP OF CORP AFFAIRS & ADMIN)","role_mark":"O","role_mark_label":"Officer (SVP OF CORP AFFAIRS & ADMIN)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP OF CORP AFFAIRS & ADMIN.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1355.0,"shares_display":"1,355","price_per_share":36.3757,"price_display":"36.38","price_state":"stated","total_value":49289.0735,"total_display":"49,289.07","total_whole":"49,289","shares_owned_after":1284.0,"shares_owned_after_display":"1,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-19","scope":"insider"},{"id":6425769,"accession":"0001415889-22-008896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-008896","line_url":"/filing/0001415889-22-008896#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709113","owner_name":"Cavanaugh Sarah","owner_display_name":"Cavanaugh Sarah","owner_url":"/insider/0001709113","role":"Officer (SVP OF CORP AFFAIRS & ADMIN)","role_mark":"O","role_mark_label":"Officer (SVP OF CORP AFFAIRS & ADMIN)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP OF CORP AFFAIRS & ADMIN.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31312.0,"shares_display":"31,312","price_per_share":36.7342,"price_display":"36.73","price_state":"stated","total_value":1150221.2704,"total_display":"1,150,221.27","total_whole":"1,150,221","shares_owned_after":1284.0,"shares_owned_after_display":"1,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":5319554,"accession":"0001179110-21-010820","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-010820","line_url":"/filing/0001179110-21-010820#line-3","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709113","owner_name":"Cavanaugh Sarah","owner_display_name":"Cavanaugh Sarah","owner_url":"/insider/0001709113","role":"Officer (SVP of Corp Affairs & Admin)","role_mark":"O","role_mark_label":"Officer (SVP of Corp Affairs & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Corp Affairs & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7323.0,"shares_display":"7,323","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":292920.0,"total_display":"292,920.00","total_whole":"292,920","shares_owned_after":408.0,"shares_owned_after_display":"408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider"},{"id":4136200,"accession":"0001179110-21-009818","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-21-009818","line_url":"/filing/0001179110-21-009818","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709113","owner_name":"Cavanaugh Sarah","owner_display_name":"Cavanaugh Sarah","owner_url":"/insider/0001709113","role":"Officer (SVP of Corp Affairs & Admin)","role_mark":"O","role_mark_label":"Officer (SVP of Corp Affairs & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Corp Affairs & Admin.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7323.0,"shares_display":"7,323","price_per_share":43.26155496381264,"price_display":"43.26","price_state":"stated","total_value":316804.367,"total_display":"316,804.37","total_whole":"316,804","shares_owned_after":3429.0,"shares_owned_after_display":"3,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider","n_lines":3},{"id":3186738,"accession":"0001179110-20-007218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-007218","line_url":"/filing/0001179110-20-007218#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709113","owner_name":"Cavanaugh Sarah","owner_display_name":"Cavanaugh Sarah","owner_url":"/insider/0001709113","role":"Officer (SVP of Corp Affairs & Admin)","role_mark":"O","role_mark_label":"Officer (SVP of Corp Affairs & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Corp Affairs & Admin.","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1050.0,"shares_display":"1,050","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":5071.5,"total_display":"5,071.50","total_whole":"5,072","shares_owned_after":1367.0,"shares_owned_after_display":"1,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000744218","name":"Celldex Therapeutics, Inc.","url":"/issuer/0000744218","role":"Officer (SVP OF CORP AFFAIRS & ADMIN)","n_filings":5,"first_seen":"2020-06-11","last_seen":"2024-06-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709113","retrieved_at":"2026-08-24T00:42:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}